vesnarinone has been researched along with tetradecanoylphorbol acetate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, BB; Manna, SK | 1 |
Matsumori, A; Nunokawa, Y; Sasayama, S | 1 |
2 other study(ies) available for vesnarinone and tetradecanoylphorbol acetate
Article | Year |
---|---|
Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis.
Topics: Apoptosis; Biological Transport; Ceramides; Chloramphenicol O-Acetyltransferase; DNA; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Genes, MDR; Genes, Reporter; HeLa Cells; Humans; Hydrogen Peroxide; I-kappa B Proteins; Immunosuppressive Agents; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Lipid Peroxidation; Lipopolysaccharides; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; NF-kappa B; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Okadaic Acid; Phosphorylation; Protein Binding; Pyrazines; Quinolines; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription Factor RelA; Tumor Necrosis Factor-alpha; U937 Cells; Uridine | 2000 |
Pimobendan inhibits the activation of transcription factor NF-kappaB: a mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase.
Topics: Amrinone; Animals; Cardiotonic Agents; Colforsin; Cytokines; Humans; Interleukin-1; Luciferases; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phosphodiesterase Inhibitors; Pyrazines; Pyridazines; Quinolines; Tetradecanoylphorbol Acetate; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |